Role of proton magnetic resonance spectroscopy in preoperative evaluation of patients with mesial temporal lobe epilepsy

Journal of the Neurological Sciences

Volumn 285, Issue 1-2, 2009, Pages 212-219

  Chernov, Mikhail F ^a,c   Ochiai, Taku ^a   Ono, Yuko ^a   Muragaki, Yoshihiro ^a   Yamane, Fumitaka ^b   Taira, Takaomi ^a   Maruyama, Takashi ^a   Tanaka, Masahiko ^a   Iseki, Hiroshi ^a   Kubo, Osami ^a   Okada, Yoshikazu ^a   Hori, Tomokatsu ^a   Takakura, Kintomo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Biological Scientific Research Institute of the State University   (Russian Federation)

Author keywords

Hippocampal sclerosis; Low grade glioma; Mesial temporal lobe epilepsy; Proton magnetic resonance spectroscopy; Seizure outcome; Surgery

Indexed keywords

LACTIC ACID; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AMYGDALOHIPPOCAMPECTOMY; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MESIAL TEMPORAL LOBE EPILEPSY; METABOLIC PARAMETERS; NEUROSURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BRAIN; BRAIN NEOPLASMS; EPILEPSY, TEMPORAL LOBE; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PREOPERATIVE CARE; PROTONS; RETROSPECTIVE STUDIES; SCLEROSIS; SEIZURES; YOUNG ADULT;

EID: 69549126024     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.07.004     Document Type: Article

References (45)

1. Spencer S.S. When should temporal-lobe epilepsy be treated surgically?. Lancet Neurol 1 (2002) 375-382
2. Wieser H.G., Ortega M., Friedman A., and Yonekawa Y. Long-term seizure outcomes following amygdalohippocampectomy. J Neurosurg 98 (2003) 751-763
3. Clusmann H., Kral T., Fackeldey E., Blumcke I., Helmstaedter C., von Oertzen J., et al. Lesional mesial temporal lobe epilepsy and limited resections: prognostic factors and outcome. J Neurol Neurosurg Psychiatry 75 (2004) 1589-1596
4. Cohen-Gadol A.A., Bradley C.C., Williamson A., Kim J.H., Westerveld M., Duckrow R.B., et al. Normal magnetic resonance imaging and medial temporal lobe epilepsy: the clinical syndrome of paradoxical temporal lobe epilepsy. J Neurosurg 102 (2005) 902-909
5. Quarato P.P., Di Gennaro G., Mascia A., Grammaldo L.G., Meldolesi G.N., Picardi A., et al. Temporal lobe epilepsy surgery: different surgical strategies after a non-invasive diagnostic protocol. J Neurol Neurosurg Psychiatry 76 (2005) 815-824
6. Sindou M., Guenot M., Isnard J., Ryvlin P., Fischer C., and Mauguiere F. Temporo-mesial epilepsy surgery: outcome and complications in 100 consecutive adult patients. Acta Neurochir (Wien) 148 (2006) 39-45
7. Hori T., Yamane F., Ochiai T., Kondo S., Shimizu S., Ishii K., et al. Selective subtemporal amygdalohippocampectomy for refractory temporal lobe epilepsy: operative and neuropsychological outcomes. J Neurosurg 106 (2007) 134-141
8. Cendes F., Andermann F., Dubeau F., Matthews P.M., and Arnold D.L. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy: evidence from proton MR spectroscopic imaging. Neurology 49 (1997) 1525-1533
9. Cendes F., Caramanos Z., Andermann F., Dubeau F., and Arnold D.L. Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateralization of temporal lobe epilepsy: a series of 100 patients. Ann Neurol 42 (1997) 737-746
10. Laxer K.D. Clinical applications of magnetic resonance spectroscopy. Epilepsia 38 Suppl.4 (1997) S13-S17
11. Vermathen P., Ende G., Laxer K.D., Knowlton R.C., Matson G.B., and Weiner M.W. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Ann Neurol 42 (1997) 194-199
12. Connelly A., Van Paesschen W., Porter D.A., Johnson C.L., Duncan J.S., and Gadian D.G. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 51 (1998) 61-66
13. 1H MRSI for outcome in temporal lobectomy. Neurology 53 (1999) 694-698
14. 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 45 (1999) 369-376
15. Eberhardt K.E., Stefan H., Buchfelder M., Pauli E., Hopp P., Huk W., et al. The significance of bilateral CSI changes for the postoperative outcome in temporal lobe epilepsy. J Comput Assist Tomogr 24 (2000) 919-926
16. Li L.M., Cendes F., Antel S.B., Andermann F., Serles W., Dubeau F., et al. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy. Ann Neurol 47 (2000) 195-200
17. Someya Y., Obata T., Suhara T., Ota Y., Ikehira H., Tanada S., et al. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy. Seizure 9 (2000) 274-279
18. Kuzniecky R., Palmer C., Hugg J., Martin R., Sawrie S., Morawetz R., et al. Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss?. Arch Neurol 58 (2001) 2048-2053
19. 1H-MRS metabolic abnormalities in temporal lobe epilepsy. Epilepsia 42 (2001) 417-422
20. Meyer P.T., Cortes-Blanco A., Pourdehnad M., Levy-Reis I., Desiderio L., Jang S., et al. Inter-modality comparisons of seizure focus lateralization in complex partial seizures. Eur J Nucl Med 28 (2001) 1529-1540
21. Park S.W., Chang K.H., Kim H.D., Song I.C., Lee D.S., Lee S.K., et al. Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 22 (2001) 625-631
22. Serles W., Li L.M., Antel S.B., Cendes F., Gotman J., Olivier A., et al. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 42 (2001) 190-197
23. Stefan H., Feichtinger M., Pauli E., Schafer I., Eberhardt K.W., Kasper B.S., et al. Magnetic resonance spectroscopy and histopathological findings in temporal lobe epilepsy. Epilepsia 42 (2001) 41-46
24. Antel S.B., Li L.M., Cendes F., Collins D.L., Kearney R.E., Shinghal R., et al. Predicting surgical outcome in temporal lobe epilepsy patients using MRI and MRSI. Neurology 58 (2002) 1505-1512
25. Guye M., Le Fur Y., Confort-Gouny S., Ranjeva J.P., Bartolomei F., Regis J., et al. Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study. Epilepsia 43 (2002) 1197-1209
26. 1H MRS and DWI in evaluation of temporal lobe epilepsy. Neurology 58 (2002) 1745-1753
27. Knowlton R.C., Abou-Khalil B., Sawrie S.M., Martin R.C., Faught R.E., and Kuzniecky R.I. In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch Neurol 59 (2002) 1882-1886
28. 1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy. Neurology 58 (2002) 821-823
29. Hammen T., Stefan H., Eberhardt K.E., W-Huk B.H., and Tomandl B.F. Clinical applications of 1H-MR spectroscopy in the evaluations of epilepsies - what do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies?. Acta Neurol Scand 108 (2003) 223-238
30. Cohen-Gadol A.A., Pan J.W., Kim J.H., Spencer D.D., and Hetherington H.H. Mesial temporal lobe epilepsy: a proton magnetic resonance spectroscopy study and a histopathological analysis. J Neurosurg 101 (2004) 613-620
31. 1H magnetic resonance spectroscopy in pre-operative evaluation for epilepsy surgery: a meta-analysis. Epilepsy Res 71 (2006) 149-158
32. 1H-MRS and neuropathology. NMR Biomed 21 (2008) 545-552
33. 1H MR spectroscopy in histopathological subgroups of mesial temporal lobe epilepsy. Eur Radiol 19 (2009) 400-408
34. Simister R.J., McLean M.A., Barker G.J., and Duncan J.S. Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection. Epilepsy Res 83 (2009) 168-176
35. Chernov M., Yamane F., Ochiai T., Hayashi M., Izawa M., Ono Y., et al. Proton MRS in temporal lobe epilepsy. J Jpn Epil Soc 22 (2004) 29-30 (Abstract)
36. Moller-Hartmann W., Herminghaus S., Krings T., Marquardt G., Lanfermann H., Pilatus U., et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44 (2002) 371-381
37. Chernov M.F., Hayashi M., Izawa M., Ono Y., and Hori T. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile. Int J Clin Oncol 11 (2006) 375-384
38. 1H-MRS). Neuroradiol J 21 (2008) 338-349
39. Hori T., Tabuchi S., Kurosaki M., Kondo S., Takenobu A., and Watanabe T. Subtemporal amygdalohippocampectomy for treating medically intractable temporal lobe epilepsy. Neurosurgery 33 (1993) 50-57
40. In: Louis D.N., Ohgaki H., Wiestler O.D., and Cavenee W.K. (Eds). WHO classification of tumours of the central nervous system (2007), IARC, Lyon
41. Engel J.J., van Ness P.C., Rasmussen T.B., and Ojemann L.M. Outcome with respect to epileptic seizures. In: Engel J.J. (Ed). Surgical treatment of the epilepsies. ed.2 (1993), Raven Press, New York 609-621
42. Clark J.B. N-Acetyl Aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20 (1998) 271-276
43. Moffett J.R., Ross B., Arun P., Madhavarao C.N., and Namboodiri A.M.A. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81 (2007) 89-131
44. Bhakoo K.K., and Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74 (2000) 254-262
45. 1H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur J Radiol 67 (2008) 250-257